STOCK TITAN

NaturalShrimp: $11.9K cash, going-concern warning

At September 30, 2026, cash was $11,886 and current liabilities were $8,269,826; disclosure controls were ineffective.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

NaturalShrimp Inc (SHMP) reported a net loss of $83,417 for the three months ended September 30, 2026, all of which was general and administrative expense. Operating activities used $67,574 of cash, while financing provided $49,000 from Series M preferred shares. Cash was $11,886 and current liabilities were $8,269,826 at September 30, 2026.

Effective June 25, 2026, Hydrenesis granted NaturalShrimp a perpetual, worldwide, exclusive and sublicensable license to commercialize technology in aquaculture and related fields. Former executives cancelled Series A and Series F preferred shares totaling $43,612,500, recorded as a capital contribution. NaturalShrimp transitioned back to going-concern accounting, but disclosed substantial doubt about its ability to continue as a going concern within one year after the financial statements were issued, citing limited operations, limited cash and significant net liabilities. It reported defaults on $1,079,832 of notes payable and $933,993 of accrued dividends, and said disclosure controls were ineffective because of material weaknesses in internal controls.

After quarter-end, on October 19, 2026, the company received $50,000 in gross proceeds for 50 Series Q preferred shares to be issued.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

4 major · 4 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Major point. Forward-looking: it has not happened yet and may not happen.Going-concern doubt extends through one year after the statements were issued.
  • Major pointDisclosure controls were ineffective at September 30, 2026 because of material weaknesses.
  • Major point$1,079,832 of notes payable was in default at September 30, 2026. 56% of market cap
  • Major point$933,993 of accrued dividends was in default at September 30, 2026. 49% of market cap

Filing Explained

The completed 60 million-share exchange reduces existing holders’ percentage ownership, absent offsets; no preferred shares had yet been issued under the technology arrangement.

The company reports exchanging four Series G preferred shares on 2026-06-30 for 60 million common shares, bringing shares outstanding to 1,337,546,746 at 2026-09-30 from 1,277,546,746 at 2026-03-31; absent offsetting changes, issuing those additional shares reduces existing holders’ percentage ownership.

Under the technology arrangement, the company agreed to issue Series P and P-2 preferred shares to David Antelo and Hydrenesis, but reported none issued by 2026-09-30. Additional preferred shares may be earned if specified milestones are met.

Cash $11,886 As of September 30, 2026.
Current liabilities $8,269,826 As of September 30, 2026.
Net loss $83,417 Three months ended September 30, 2026.
Cash used in operating activities $67,574 Three months ended September 30, 2026.
Defaulted notes payable $1,079,832 As of September 30, 2026.
Defaulted accrued dividends $933,993 As of September 30, 2026.
Series A and Series F preferred shares cancelled $43,612,500 Cancelled during September 2026 and recorded as a capital contribution.
Series Q gross proceeds $50,000 Received October 19, 2026 for 50 Series Q preferred shares to be issued.
going concern financial
"substantial doubt about its ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
liquidation basis of accounting financial
"using the liquidation basis of accounting when liquidation is imminent"
temporary equity financial
"classified in temporary equity"
Equity-like securities that accounting rules require to be reported separately from permanent shareholders’ equity because the holder can force or the issuer is obligated to settle them in cash or other assets (or they will be settled on a specified date). Examples include mandatorily redeemable shares and certain convertible instruments with required cash settlement; on the balance sheet they appear between liabilities and shareholders’ equity (often called mezzanine or temporary equity) rather than as part of common equity.
cumulative dividend financial
"A 12% per annum cumulative dividend on the stated value"
A cumulative dividend is a feature on certain dividend-paying securities—most often preferred shares—where any missed or unpaid dividend payments build up like an IOU and must be paid to those shareholders before common shareholders receive dividends. For investors this matters because it makes expected income more reliable and gives holders priority on future payouts, which affects yield, perceived safety, and the security’s value compared with noncumulative alternatives.
volume weighted average price financial
"lowest volume weighted average price (VWAP) for the common stock"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did SHMP report substantial doubt about its ability to continue as a going concern?

NaturalShrimp cited limited operations, limited cash and significant net liabilities as the basis for substantial doubt about its ability to continue as a going concern within one year after the financial statements were issued. It said raising private-market funds and generating operating revenue were hoped-for plans, but neither was finalized or considered probable within 12 months.

How much did SHMP receive from its Series Q financing after quarter-end?

On October 19, 2026, NaturalShrimp received $50,000 in gross proceeds for 50 Series Q preferred shares to be issued.

What equity did SHMP agree to issue for the Hydrenesis technology license?

NaturalShrimp agreed to issue Series P preferred stock to David Antelo and Series P-2 preferred stock to Hydrenesis. Additional preferred stock may be earned by both upon achievement of milestones in the agreement; no preferred shares had been issued as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false Q2 --03-31 0001465470 0001465470 2026-04-01 2026-09-30 0001465470 2026-11-10 0001465470 2026-09-30 0001465470 SHMP:SeriesFRedeemableConvertiblePreferredStockMember 2026-09-30 0001465470 SHMP:SeriesMRedeemableConvertiblePreferredStockMember 2026-09-30 0001465470 SHMP:SeriesAConvertiblePreferredStockMember 2026-09-30 0001465470 2026-03-31 0001465470 2026-07-01 2026-09-30 0001465470 2026-06-30 0001465470 us-gaap:PreferredStockMember SHMP:SeriesAConvertiblePreferredStockMember 2026-06-25 0001465470 us-gaap:CommonStockMember 2026-06-25 0001465470 us-gaap:AdditionalPaidInCapitalMember 2026-06-25 0001465470 SHMP:StockToBeIssuedMember 2026-06-25 0001465470 SHMP:SubscriptionReceivableMember 2026-06-25 0001465470 us-gaap:RetainedEarningsMember 2026-06-25 0001465470 2026-06-25 0001465470 us-gaap:PreferredStockMember SHMP:SeriesAConvertiblePreferredStockMember 2026-06-30 0001465470 us-gaap:CommonStockMember 2026-06-30 0001465470 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001465470 SHMP:StockToBeIssuedMember 2026-06-30 0001465470 SHMP:SubscriptionReceivableMember 2026-06-30 0001465470 us-gaap:RetainedEarningsMember 2026-06-30 0001465470 us-gaap:PreferredStockMember SHMP:SeriesAConvertiblePreferredStockMember 2026-06-26 2026-06-30 0001465470 us-gaap:CommonStockMember 2026-06-26 2026-06-30 0001465470 us-gaap:AdditionalPaidInCapitalMember 2026-06-26 2026-06-30 0001465470 SHMP:StockToBeIssuedMember 2026-06-26 2026-06-30 0001465470 SHMP:SubscriptionReceivableMember 2026-06-26 2026-06-30 0001465470 us-gaap:RetainedEarningsMember 2026-06-26 2026-06-30 0001465470 2026-06-26 2026-06-30 0001465470 us-gaap:PreferredStockMember SHMP:SeriesAConvertiblePreferredStockMember 2026-07-01 2026-09-30 0001465470 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001465470 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001465470 SHMP:StockToBeIssuedMember 2026-07-01 2026-09-30 0001465470 SHMP:SubscriptionReceivableMember 2026-07-01 2026-09-30 0001465470 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001465470 us-gaap:PreferredStockMember SHMP:SeriesAConvertiblePreferredStockMember 2026-09-30 0001465470 us-gaap:CommonStockMember 2026-09-30 0001465470 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001465470 SHMP:StockToBeIssuedMember 2026-09-30 0001465470 SHMP:SubscriptionReceivableMember 2026-09-30 0001465470 us-gaap:RetainedEarningsMember 2026-09-30 0001465470 2025-03-31 0001465470 2025-04-01 2025-09-30 0001465470 2025-09-30 0001465470 SHMP:StreetervilleAndBuckstownCapitalMember 2025-02-11 0001465470 SHMP:IntellectualPropertyAgreementWithHydrenesisIncMember 2026-03-01 2026-03-31 0001465470 SHMP:StreetervilleAndBuckstownCapitalMember 2025-02-28 0001465470 us-gaap:PreferredStockMember 2026-06-25 0001465470 SHMP:FormerEmployeesMember 2026-09-30 0001465470 2026-09-01 2026-09-30 0001465470 SHMP:SeriesAAndFPreferredStockMember 2026-09-01 2026-09-30 0001465470 SHMP:HydrenesisIncMember 2026-09-01 2026-09-30 0001465470 SHMP:SeriesEConvertiblePreferredStockMember 2021-04-14 0001465470 SHMP:SeriesEConvertiblePreferredStockMember 2021-04-14 2021-04-14 0001465470 SHMP:SeriesGRedeemableConvertiblePreferredStockMember 2023-12-01 0001465470 SHMP:SeriesGRedeemableConvertiblePreferredStockMember 2023-12-01 2023-12-01 0001465470 us-gaap:SeriesGPreferredStockMember 2026-06-30 2026-06-30 0001465470 us-gaap:CommonStockMember 2026-06-30 2026-06-30 0001465470 us-gaap:PrivatePlacementMember SHMP:SeriesMRedeemableConvertiblePreferredStockMember 2026-05-06 2026-05-06 0001465470 us-gaap:PrivatePlacementMember SHMP:SeriesMRedeemableConvertiblePreferredStockMember 2026-05-06 0001465470 us-gaap:PrivatePlacementMember SHMP:SeriesMRedeemableConvertiblePreferredStockMember srt:MaximumMember 2026-05-06 2026-05-06 0001465470 SHMP:SeriesMRedeemableConvertiblePreferredStockMember 2026-05-06 0001465470 SHMP:SeriesMRedeemableConvertiblePreferredStockMember 2026-05-06 2026-05-06 0001465470 SHMP:SeriesMRedeemableConvertiblePreferredStockMember 2026-07-01 2026-09-30 0001465470 SHMP:SeriesQPreferredStockMember 2026-10-19 2026-10-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended September 30, 2026

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period from _________ to _________

 

Commission file number: 000-54030

 

NATURALSHRIMP INCORPORATED

(Exact name of registrant as specified in its charter)

 

Nevada   74-3262176

(State or other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

     

P.O. Box 1256

Dallas, Texas

  75225
(Address of Principal Executive Offices)   (Zip Code)

 

(972) 951-8035

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of exchange on which registered
None   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ No ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a small reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
       
Non-accelerated filer ☒ Smaller reporting company ☒
       
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act: ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

As of November 10, 2026, there were 1,377,546,746 shares of the registrant’s common stock outstanding.

 

 

 

 

 

 

NATURALSHRIMP INCORPORATED

FORM 10-Q

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

 

  Page
   
PART I. FINANCIAL INFORMATION  
     
ITEM 1. Financial Statements  
     
  Condensed Balance Sheet as of September 30, 2026 3
     
  Condensed Statement of Operations for the three months ended September 30, 2026 4
     
  Condensed Statement of Cash Flows for the three months ended September 30, 2026 5
     
  Condensed Statement of Changes in Shareholders Equity for the three months ended September 30, 2026 6
     
  Condensed Statement of Net Liabilities in Liquidation as of March 31, 2026 7
     
  Condensed Statement of Changes of Net Liabilities in Liquidation for the six months ended September 30, 2025 8
     
  Notes to Condensed Financial Statements 9
     
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
     
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk 18
     
ITEM 4. Controls and Procedures 18
     
PART II. OTHER INFORMATION 19
     
ITEM 1. Legal Proceedings 19
     
ITEM 1A. Risk Factors 19
     
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 19
     
ITEM 3. Defaults Upon Senior Securities 19
     
ITEM 4. Mine Safety Disclosures 19
     
ITEM 5. Other Information 19
     
ITEM 6. Exhibits 19
     
SIGNATURES 20

 

2

 

 

NATURALSHRIMP INCORPORATED

CONDENSED BALANCE SHEET

AS OF SEPTEMBER 30, 2026

(Going Concern Basis)

 

      
ASSETS     
Current assets     
Cash  $11,886 
Prepaid expenses   5,522 
      
Total current assets   17,408 
      
Total assets  $17,408 
      
LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIT     
Current liabilities     
Accounts payable  $1,708,462 
Accrued expenses   2,087,557 
Notes payable   1,079,832 
Dividends payable   933,993 
Mandatorily redeemable preferred shares   2,459,982 
      
Total current liabilities   8,269,826 
      
Total liabilities   8,269,826 
      
Commitments and contingencies   - 
      
Series F Redeemable Convertible Preferred stock, $0.0001 par value, 750,000 shares authorized, 0 shares issued and outstanding at September 30, 2026   - 
      
Series M Convertible Preferred stock, $0.0001 par value, 372 shares authorized, 191 issued and outstanding as of September 30, 2026   176,877 
      
Stockholders’ deficit     
Series A Convertible Preferred stock, $0.0001 par value, 5,000,000 shares authorized, 0 shares issued and outstanding at September 30, 2026   - 
      
Common stock, $0.0001 par value, 1,400,000,000 shares authorized, 1,337,546,746 and 1,277,546,746 shares issued and outstanding at September 30, 2026 and March 31, 2026, respectively   133,818 
      
Additional paid in capital   174,522,214 
Stock to be issued   390,024 
Subscription receivable   (56,250)
Accumulated deficit   (183,419,101)
Adjustment to net assets in liquidation   - 
Total stockholders’ deficit   (8,429,295)
      
Total liabilities, mezzanine and stockholders’ deficit  $17,408 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

3

 

 

NATURALSHRIMP INCORPORATED

STATEMENT OF OPERATIONS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026

(Going Concern Basis)

 

  

 
Operating expenses:     
General and administrative   83,417 
Total operating expenses   83,417 
      
Net loss from operations   (83,417)
      
Income (loss) before income taxes   (83,417)
      
Provision for income taxes   - 
      
Net income   (83,417)
      
Earnings per share (Basic and Diluted)  $(0.00)
      
WEIGHTED AVERAGE SHARES OUTSTANDING (Basic and Diluted)   1,337,546,746 

 

4

 

 

NATURALSHRIMP INCORPORATED

STATEMENT OF CASH FLOWS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026

 

  

 
CASH FLOWS FROM OPERATING ACTIVITIES     
Net income  $(83,417)
      
Adjustments to reconcile net loss to net cash used in operating activities     
Changes in operating assets and liabilities:     
Prepaid expenses   (2,178)
Accounts payable   18,021 
      
Cash provided by operating activities   (67,574)
      
CASH FLOWS FROM FINANCING ACTIVITIES     
      
Proceeds from sale of Series M Preferred Shares   49,000 
      
Cash provided by financing activities   49,000 
      
NET CHANGE IN CASH   (18,574)
      
CASH AT BEGINNING OF PERIOD   30,460 
      
CASH AT END OF PERIOD  $11,886 
      
Non-Cash Investing and Financing Activities:     
Series M P/S dividend accrual  $5,259 
Capital contribution-accrued compensation forgiveness  $1,773,831 
Capital contribution-payable forgiveness  $1,257,415 
Capital contribution-series A and F preferred shares cancellation  $43,612,500 
Capital contribution-loan forgiveness  $100,000 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

5

 

 

NATURALSHRIMP INCORPORATED

STATEMENT OF CHANGES IN SHAREHOLDERS EQUITY

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026

 

   Shares   Amount   Shares   Amount   in Capital   issued   receivable   deficit   deficit 
   Series A Preferred stock   Common stock   Additional paid   Stock to be   Subscription   Accumulated   Total stockholders’ 
   Shares   Amount   Shares   Amount   in Capital   issued   receivable   deficit   deficit 
Balance June 26, 2026   5,000,000  $500    1,277,546,746   $127,818   $127,504,311   $390,024   $(56,250)  $(183,330,844)  $(55,364,441)
                                              
Series M P/S dividend accrual   -    -    -    -    (2,619)   -    -    -    (2,619)
                                              
Series G P/S exchange   -    -    60,000,000    6,000    282,035    -    -    -    288,035 
                                              
Net loss   -    -    -    -    -    -    -    (4,840)   (4,840)
                                              
Balance June 30, 2026   5,000,000  $500    1,337,546,746   $133,818   $127,783,727   $390,024   $(56,250)  $(183,335,684)  $(55,083,865)
                                              
Series M P/S dividend accrual   -    -    -    -    (5,259)   -    -    -    (5,259)
                                              
Capital contribution-accrued compensation forgiveness   -    -    -    -    1,773,831    -    -    -    1,773,831 
                                              
Capital contribution-payable forgiveness   -    -    -    -    1,257,415    -    -    -    1,257,415 
                                              
Capital contribution-series A and F preferred shares cancellation   (5,000,000)   (500)   -    -    43,612,500    -    -    -    43,612,000 
                                              
Capital contribution-loan forgiveness   -    -    -    -    100,000    -    -    -    100,000 
                                              
Net loss   -    -    -    -    -    -    -    (83,417)   (83,417)
                                              
Balance September 30, 2026   -  $-    1,337,546,746   $133,818   $174,522,214   $390,024   $(56,250)  $(183,419,101)  $(8,429,295)

 

6

 

 

NATURALSHRIMP INCORPORATED

STATEMENT OF NET LIABILITES IN LIQUIDATION

AS OF MARCH 31, 2026

(Liquidation Basis)

 

   As of March 31, 
   2026 
Cash  $9,851 
Current assets   - 
Fixed assets and intangibles   - 
Other assets   - 
Accounts payable and accrued expenses   (6,888,615)
Notes payable and lines of credit   (1,179,832)
Other liabilities   (933,993)
Net liabilities in liquidation  $(8,992,589)

 

7

 

 

NATURALSHRIMP INCORPORATED

STATEMENT OF CHANGES IN NET LIABILITIES IN LIQUIDATION

FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2025

(Liquidation Basis)

 

   For the  
  

Six Months Ended

September 30, 2025

 
Net liabilities in liquidation, March 31, 2025  $(8,791,012)
      
Changes in assets and liabilities in liquidation:     
Cash   (52,163)
Write-off of assets   (280,195)
Transfer of fixed assets and intangibles to creditor   (35,800,000)
Settlement of accounts payable and accrued expenses   (2,147)
Extinguishment of notes payable and lines of credit   36,021,019 
Extinguishment of other liabilities   28,560 
Net changes in liabilities in liquidation   (84,926)
      
Net liabilities in liquidation, September 30, 2025  $(8,875,938)

 

The accompanying notes are an integral part of these Condensed Consolidated financial statements.

 

8

 

 

NATURALSHRIMP INCORPORATED

NOTES TO FINANCIAL STATEMENTS

 

NOTE 1 – NATURE OF THE ORGANIZATION AND BUSINESS

 

Historical Business Operations

 

NaturalShrimp Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, was a former biotechnology company that was focused on growing Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density, low-cost environment, and in fully contained and independent production facilities.

 

Receivership

 

On September 4, 2024, Streeterville Capital, LLC, a Utah limited liability company, and Bucktown Capital, LLC, a Utah limited liability company (collectively, “Lenders”), filed a Verified Emergency Motion for Appointment of Receiver (the “Motion”) under Civil Case No. 240907138, in the District Court of Salt Lake County, Utah, against NaturalShrimp, Inc. (“NaturalShrimp”).

 

The Motion alleged, among other things, that NaturalShrimp had defaulted under the terms of its loan agreements with the Lenders. The Motion sought the appointment of a Receiver to immediately take control of NaturalShrimp’s assets to preserve the same.

 

An order was entered ex parte by the Utah State Court in the Receivership Case on September 9, 2024 granting the relief requested by Lenders. The Utah State Court duly appointed Amplēo Turnaround and Restructuring, LLC (the “Receiver”) as the receiver over NaturalShrimp’s assets. The Utah State Court’s order further scheduled a hearing to be held on September 17, 2024, on a preliminary injunction to address issues raised in the Motion.

 

On November 20, 2024, the Lenders and NaturalShrimp filed a Verified Amended and Stipulated Emergency Motion for Immediate Appointment of a Receiver in the Receivership Case.

 

On November 22, 2024, the Utah State Court entered an order granting the Stipulated Motion and appointed Receiver as the receiver over the assets of NaturalShrimp. Under the Amended Receivership Order, the Receiver is the receiver over the Receivership Entities’ assets.

 

On February 11, 2025, the Receiver filed a Motion for Approval to Sell Substantially all of the Receivership Entities’ Assets to Streeterville Captial, LLC and Bucktown Captial, LLC (or Their Designees) or Any Other Party With a Higher and Better Offer Free and Clear of All Liens, Interests, Claims, and Encumbrances (the “Sale Motion”) in the Receivership Case. The Sale Motion sought the Utah State Court’s approval for the Receiver to sell substantially all of the Receivership Entities’ assets free and clear of all liens, interests, claims, and encumbrances to Streeterville and Bucktown Capital, through their designated entities, NaturalShrimp Farms, Inc. (“NV Purchaser”), a Nevada corporation, Iowa Shrimp Holdings, LLC (“IA Purchaser”), an Iowa limited liability company, Texas Shrimp Holdings, LLC (“TX Purchaser” or together with NV Purchaser and IA Purchaser, the “Purchasers”), a Texas limited liability company, for a roughly $35,703,789.87 credit bid (based on a secured and administrative claim basis) and $100,000 cash, pursuant to the terms and conditions set forth in that certain Asset Purchase Agreement (“APA”) between Trustee and Purchasers. The order to sell the assets was approved on March 30, 2025 and the title to the assets was transferred to the lenders on May 14, 2025.

 

9

 

 

Intellectual Property Agreement with Hydrenesis, Inc.

 

During March of 2026, NaturalShrimp Incorporated entered into an Intellectual Property Acquisition and Management Transition Agreement (the “Agreement”) with Hydrenesis, Inc., a Florida corporation (“Hydrenesis”), and David Antelo. Pursuant to the agreement:

 

  ● The Company agreed to transition its operations toward the commercialization of aquaculture and water treatment technologies
     
  ● Certain governance and control rights were transferred
     
  ● Hydrenesis agreed to grant the Company a license to certain intellectual property, technology rights, know-how, and related commercialization rights, subject to the terms and conditions of the agreement
     
  ● The Company’s outstanding obligation to Hydrenesis in the amount of approximately $1.3 million will be converted into equity at Closing. See Note 6 for additional information.
     
  ● The Company approved and executed Certificates of Designation for Series P, Series P-2, and Series L Preferred Stock, which are expected to be filed with the Nevada Secretary of State;
     
  ● Existing liabilities, obligations, and legacy securities, including Series A Preferred Stock and Series F Preferred Stock, will be restructured, amended, cancelled, or exchanged into Series L Preferred Stock. See Note 6 for additional information.

 

On June 25, 2026, NaturalShrimp Inc, Hydrenesis, Inc., and David Antelo entered into a First Amendment to the Intellectual Property Acquisition and Management Transition Agreement and Amended and Restated Perpetual Field-of-Use License Terms (the “Amendment”). The amendment confirmed that the intellectual property transfer contemplated by the original agreement did not occur. Instead, effective June 25, 2026, Hydrenesis granted the Company a perpetual, worldwide, exclusive, and sublicensable license to use and commercialize the licensed technology in aquaculture and related fields. However, as of September 30, 2026, no Series P or Series L preferred shares were issued.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Condensed Consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“US GAAP”). As the Company’s liquidation was considered imminent on March 30, 2025, the Company has presented its financial statements under the liquidation basis of accounting as of March 31, 2025 and for the six month period ended September 30, 2025. Further, as a result of the intellectual property agreement with Hydrenesis and Mr. Antelo, the Company believes that it transitioned from liquidation basis to a going concern as of June 25, 2026 (i.e. the date that the perpetual license was transferred). Thus, the Company has also presented a going concern balance sheet as of September 30, 2026 and a going concern statement of operations, cash flow statement and statement of changes in shareholders equity for the three month period ended September 30, 2026. The Company has not presented an additional statement of operations, cash flow statement and statement of changes in shareholders’ equity for the going concern period from June 26, 2026 through September 30, 2026 as it does not believe it would be material to a reasonable investor.

 

Extinguishment of Liabilities

 

The Company determines whether a liability has been extinguished in accordance ASC 405-20, Extinguishment of liabilities. Specifically, a liability has been extinguished if either i) the debtor pays the creditor and is relieved of its obligation for the liability or ii) the debtor is legally released from being the primary obligor under the liability, either judicially or by the creditor.

 

10

 

 

Liquidation Basis of Accounting

 

In accordance with ASC 205-30, Liquidation Basis of Accounting, the Company prepares its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is considered imminent when either of the following occurs-i) A plan for liquidation has been approved by the person or persons with the authority to make such a plan effective, and the likelihood is remote that either execution of the plan will be blocked by other parties or the entity will return from liquidation and ii) A plan for liquidation is imposed by other forces, and the likelihood is remote that the entity will return from liquidation.

 

When using the liquidation basis of accounting, the Company will i) recognize other items that it previously had not recognized but it expects to sell in liquidation or use to settle liabilities ii) accrue costs and income that it expects to incur or earn through the end of its liquidation if and when it has a reasonable basis for estimation iii) measure its assets to reflect the estimated amount of cash or other consideration that it expects to collect in settling or disposing of those assets in carrying out its plan for liquidation and iv) measure its liabilities in accordance with the measurement provision of other topics that it would otherwise apply to those liabilities.

 

Transactions under Common Control

 

The Company recognizes transactions under common control in accordance with ASC 805-50. Specifically, when accounting for a transfer of assets or exchange of shares between entities under common control, the Company will initially measure the recognized assets and liabilities transferred at their carrying amounts in the accounts of the transferring entity at the date of transfer.

 

Going Concern

 

Due to its limited operations, limited cash and significant net liabilities as of September 30, 2026 the Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after its financial statements were issued. The Company hopes to i) raise funds in the private markets and ii) generate operating revenue to fund its business operations going forward. However, no plans were finalized as of the time of the filing and were not considered probable of occurring within 12 months of the date the financial statements were issued.

 

Preferred Share Issuances

 

Upon the issuance of preferred shares, the Company will determine if the shares should be classified as a liability in accordance with ASC 480, Distinguishing Liabilities from Equity. If the Company determines that the preferred shares should not be classified as a liability, it will then assess whether the shares should be classified as permanent or temporary equity. If classified as temporary equity, the Company will re-measure the shares at the end of each reporting period (if required) in accordance with 480-10-S99. If classified as permanent equity, the shares will not be re-measured at the end of each reporting period.

 

Recently Issued Accounting Standards

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40). The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses at each interim and annual reporting period. The amendments are effective for annual periods beginning after December 15, 2026, and reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of the new ASU to its financial statements.

 

11

 

 

NOTE 3 – TRANSITION FROM LIQUIDATION BASIS TO GOING CONCERN

 

During September of 2024, Ampleo Turnaround and Restructuring, LLC was placed as the receiver over the Company’s assets due to its significant outstanding debt. Subsequently, during February of 2025, the receiver filed a motion to sell all of the Company’s assets to Streeterville and Bucktown Capital for an approximate credit bid of $35.7 million and $0.1 million in cash. The motion was approved by the court (overseeing the motion) on March 30, 2025 with title to the assets being transferred to the creditor on May 14, 2025. The Company believes that it continued to function as a going concern until the date the motion to sell its assets was approved by the court at which time its liquidation became imminent. Furthermore, on June 25, 2026, Hydrenesis, a related party under common control, granted the Company a perpetual license to use and commercialize the licensed technology in aquaculture and related fields. The Company believes that as of that date its liquidation was no longer imminent and, as such, it transitioned back to being a going concern.

 

Based on the above, the Company has presented the following in its interim financial statements for the period ended September 30, 2026:

 

  ● A going concern balance sheet as of September 30, 2026
  ● A going concern statement of operations, cash flow statement and statement of changes in shareholders equity for the three months ended September 30, 2026
  ● A condensed consolidated statement of net liabilities in liquidation as of March 31, 2026
  ● A condensed consolidated statement of changes in net liabilities in liquidation for the six month period ended September 30, 2025

 

NOTE 4 – INTELLECTUAL PROPERTY TRANSFER

 

On June 25, 2026, Hydrenesis, a related party under common control, granted the Company a perpetual, worldwide, exclusive and sublicensable license to use and commercialize licensed technology in aquaculture and related fields (“IP”). In exchange for the transferred IP, the Company agreed to issue Series P preferred stock and series P-2 preferred stock to Mr. Antelo and Hydrenesis, respectively. Additional preferred stock may be earned by both Mr. Antelo and Hydrenesis upon achievement of certain milestones outlined in the agreement. No preferred shares were issued as of September 30, 2026.

 

In accordance with ASC 805-50, the Company recognized the perpetual license at its carrying amount in the accounts of the transferring entity at the date of transfer. As the transferor had recognized all costs related to developing the IP as research and development expense, the Company did not recognize as asset related to the transferred IP. Further, as the preferred shares were not yet authorized or issued, the Company has not presented them on the face of their balance sheet. Once the preferred shares are issued, the Company plans to recognize the shares at a $0 value on the face of its balance sheet and classify them in permanent equity.

 

NOTE 5 –CURRENT LIABILITIES

 

Accounts Payable

 

Accounts payable was comprised of various payables to a significant number of vendors. The Company is currently in active talks with the vendors to settle the outstanding payables through the issuance of preferred shares.

 

Accrued Expenses

 

Accrued expenses was primarily comprised of $1.7 million outstanding to the Company’s former legal counsel. The Company is currently in active discussion with both the former employees and former legal counsel to settle the outstanding balance through the issuance of equity instruments (warrants or preferred shares).

 

Notes Payable

 

The Company had approximately $1.1 million in outstanding loans as of September 30, 2026. The loans were primarily with former employees and were all in default as of September 30, 2026. The Company is in active negotiations with the former employees in attempt to settle the outstanding notes through the issuance of preferred shares. Per agreements with the creditors interest on the outstanding notes ceased being accrued as of September 8, 2024 (i.e. the receivership date).

 

12

 

 

Dividends Payable

 

Dividends payable relates to accrued dividends on the former Series E, F and G preferred shares. The Company is in active negotiations with the preferred shareholders in attempt to settle the outstanding payables through the issuance of preferred shares.

 

Mandatorily Redeemable Preferred Shares

 

The Company’s Series E and G preferred shares have been recognized as a liability (in accordance with ASC 480) as they were considered mandatorily redeemable as of September 30, 2026.

 

NOTE 6-CAPITAL CONTRIBUTIONS

 

Accrued Compensation Forgiveness

 

During September of 2026, accrued compensation totaling $1.8 million was forgiven by four former executives of Natural Shrimp. The Company considered the forgiveness to be a contribution from the former employees and therefore recognized the forgiveness as a reduction to accounts payable and a corresponding increase to additional paid in capital.

 

Series A and F Preferred Shares Cancellation

 

During September of 2026, the Company’s Series A and Series F preferred shares (totaling $43,612,500), which were all owned by former executives, were cancelled. The Company considered the cancellation to be a contribution from the former employees and therefore recognized the cancellation as an increase to additional paid in capital.

 

Loan Forgiveness

 

During September of 2026, loans from former employees totaling $100,000 were forgiven. The Company considered the forgiveness to be a contribution from the former employees and therefore recognized the forgiveness as a reduction to notes payable and a corresponding increase to additional paid in capital.

 

Related Party Liability to Hydrenesis

 

During September of 2026, a related party loan from Hydrenesis totaling $1,257,415 was forgiven. The Company considered the forgiveness to be a contribution from the related party and therefore recognized the forgiveness as a reduction to accounts payable and a corresponding increase to additional paid in capital.

 

13

 

 

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

Series E

 

On April 14, 2021, the Board authorized the issuance of 10,000 shares of the Company’s Series E Preferred Stock and filed a Certificate of Designation (“COD”) of Preferences of the Series E Convertible Preferred Stock with the State of Nevada. The shares of Series E Preferred Stock have a stated value of $1,200 per share and are convertible into shares of common stock at the election of the holder of the Series E Preferred Stock at any time at a price of $0.35 per share, subject to adjustment (the “Conversion Price”). The Series E Preferred Stock is convertible into that number of shares of common stock determined by dividing the Series E Stated Value (plus any and all other amounts which may be owing in connection therewith) by the Conversion Price, subject to certain beneficial ownership limitations. Each holder of Series E Preferred Stock shall be entitled to receive, with respect to each share of Series E Preferred Stock then outstanding and held by such holder, dividends at the rate of twelve percent (12%) per annum, payable quarterly. Each share of Series E Preferred Stock shall be redeemed by the Company on the date that is no later than one calendar year from the date of its issuance. The Series E Preferred Stock are also redeemable at the Company’s option, at percentages ranging from 115% to 125% for the first 180 days, based on the passage of time. The holders of Series E Preferred Stock rank senior to the Common Stock and Common Stock Equivalents (as defined in the Series E Designation) with respect to payment of dividends and rights upon liquidation and will vote together with the holders of the Common Stock on an as-converted basis, subject to beneficial ownership limitations, on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). Based upon a subsequent financing, the holder has the option to exchange (in lieu of conversion), all or some of the shares of Series E Preferred Stock then held for any securities or units issued in a subsequent financing on a $1.00 for $1.00 basis. In the event of a Fundamental Transaction, the holder has the option to request that the Company or the successor entity shall purchase the Preferred Stock from the Holder on the date of such request by paying to the Holder cash in an amount equal to the Black Scholes value. Upon any triggering event as set forth in the COD, including a change in control or the Company shall fail to have available a sufficient number of authorized and unreserved shares of common stock to issue to such holder upon a conversion, each holder shall have the right, exercisable at the sole option of such holder, to require the Company to redeem all of the Series E Preferred Stock then held by such holder for a redemption price, in cash, equal to the Triggering Redemption Amount (150% of the Stated Value and all accrued but unpaid dividends and all liquidated damages, late fees and other costs), and increase the dividend rate on all of the outstanding Preferred Stock held by such Holder to 18% per annum thereafter. Upon any liquidation, dissolution or winding-up of the Company, the holders shall be entitled to receive out of the assets of the Company an amount equal to the stated value, plus any accrued and unpaid dividends and any other fees or liquidated damages then due and owing for each share of Preferred Stock, before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Corporation. Because the preferred shares were mandatorily redeemable as of September 30, 2026 they have been classified as a liability.

 

Series G

 

On December 1, 2023, the Board authorized the issuance of 10,000 preferred shares to be designated as Series G Preferred Stock (“Series G Preferred Stock”). The Series G Preferred Stock has a par value of $0.0001, a stated value of $1,200 and bear dividends at the rate of 8% per annum, payable quarterly, to be paid in cash or in-kind, at the discretion of the Company. The Series G Preferred Stock will vote together with the common stock on an as-converted basis subject to the beneficial ownership limitations. The Series G Preferred Stock is required to be redeemed by the Company no later than one calendar year from the date of its issuance. The Series G Preferred Stock is also redeemable at the option of the Company at any time after the original issued date, upon 3 business days’ notice, at a premium rate which is (a) 1.15 if all of the Series G Preferred Stock is redeemed within 90 calendar days from the issuance date thereof; (b) 1.2 if all of the Series G Preferred Stock is redeemed after 90 calendar days and within 120 calendar days from the issuance date thereof; (c) 1.25 if all of the Series G PS is redeemed after 120 calendar days and within 180 calendar days from the issuance date thereof. The Company shall be permitted to redeem the Series G Preferred Stock at any time in cash upon 3 business days prior notice to the Holder or the Holder may convert the Series G Preferred Stock within 3 business days period prior to redemption. The Holder shall have the right to either redeem for cash or convert the Series G Preferred Stock into common stock within 3 business days following the consummation of a qualified offering. The conversion price is based on the discounted market price which is the lower of: (i) A fixed price equaling the closing bid price for the common stock on the trading day preceding the execution of the SPA ; or (ii) 100% of the lowest volume weighted average price (“VWAP)” for the common stock during 10 trading days preceding the conversion request, subject to adjustment. Because the preferred shares were mandatorily redeemable as of September 30, 2026 they have been classified as a liability.

 

On June 30, 2026, the Company exchanged 4 shares of Series G preferred stock for the issuance of 60,000,000 common shares.

 

14

 

 

Series M

 

On May 6, 2026, the Company signed a Securities Purchase Agreement (SPA) with GHS Investments LLC (“GHS”), for the private placement of a new class of Series M Convertible Preferred Stock. At the Initial Closing, the Company sold 132 shares of Series M Preferred at $1,000 per share for gross proceeds of $132,000 (or $120,000 net of $12,000 in legal fees). In addition, the Company also issued 10 additional “Commitment Shares” as an equity kicker resulting in the issuance of 142 total shares at closing. Up to 230 additional shares may be sold in Additional Closings, at the Purchaser’s discretion, subject to certain Equity Conditions bringing the maximum issuance to 372 Series M shares. Each share has a Stated Value of $1,200.

 

The preferred shares include the following key terms:

 

  ● A 12% per annum cumulative dividend on the stated value (of $1,200) to be paid quarterly in cash or in additional preferred shares at the Company’s election
  ● A conversion option into common shares per the Certificate of Designation
  ● An issuer call/redemption right exercisable per the Certificate of Designation and
  ● A redemption trigger on upon an event of default

 

In accordance with ASC 480, Distinguishing Liabilities and Equity and ASC 815, Derivatives and Hedging, the Company concluded that the preferred shares did not contain an embedded derivative and should be classified in temporary equity (as a result of mandatory redemption upon on event of default). Further, as the dividends can be paid in either cash or additional preferred shares the accrued dividends are recognized as an increase in temporary equity.

 

During the three months ended September 30, 2026, the Company sold an additional Series M preferred shares for gross proceeds of $49,000.

 

Common Stock

 

As of September 30, 2026, the Company had 1,400,000,000 shares of common stock authorized with a par value of $0.0001. Of this amount, 1,337,546,746 shares were outstanding.

 

NOTE 7 – SUBSEQUENT EVENTS

 

In accordance with ASC 855, Subsequent Events, the Company evaluated all events or transactions that occurred after the balance sheet date but before the financial statements were issued. To that extent, the Company noted the following:

 

Series Q Financing

 

On October 19, 2026,  the Company received $50,000 in gross proceeds for (to be issued) 50 Series Q preferred shares.

 

15

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview

 

NaturalShrimp Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a former biotechnology company that was focused on growing Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density, low-cost environment, and in fully contained and independent production facilities.

 

Receivership and Liquidation

 

On September 4, 2024, Streeterville Capital, LLC, a Utah limited liability company, and Bucktown Capital, LLC, a Utah limited liability company (collectively, “Lenders”), filed a Verified Emergency Motion for Appointment of Receiver (the “Motion”) under Civil Case No. 240907138, in the District Court of Salt Lake County, Utah, against NaturalShrimp, Inc. (“NaturalShrimp”).

 

The Motion alleged, among other things, that NaturalShrimp had defaulted under the terms of its loan agreements with the Lenders. The Motion sought the appointment of a Receiver to immediately take control of NaturalShrimp’s assets to preserve the same.

 

An order was entered ex parte by the Utah State Court in the Receivership Case on September 9, 2024 granting the relief requested by Lenders. The Utah State Court duly appointed Amplēo Turnaround and Restructuring, LLC (the “Receiver”) as the receiver over NaturalShrimp’s assets. The Utah State Court’s order further scheduled a hearing to be held on September 17, 2024, on a preliminary injunction to address issues raised in the Motion.

 

On November 20, 2024, the Lenders and NaturalShrimp filed a Verified Amended and Stipulated Emergency Motion for Immediate Appointment of a Receiver in the Receivership Case.

 

On November 22, 2024, the Utah State Court entered an order granting the Stipulated Motion and appointed Receiver as the receiver over the assets of NaturalShrimp.

 

On February 11, 2025, the Receiver filed a Motion for Approval to Sell Substantially all of the Receivership Entities’ Assets to Streeterville Captial, LLC and Bucktown Captial, LLC (or Their Designees) or Any Other Party With a Higher and Better Offer Free and Clear of All Liens, Interests, Claims, and Encumbrances (the “Sale Motion”) in the Receivership Case. The Sale Motion sought the Utah State Court’s approval for the Receiver to sell substantially all of the Receivership Entities’ assets free and clear of all liens, interests, claims, and encumbrances to Streeterville and Bucktown Capital, through their designated entities, NaturalShrimp Farms, Inc. (“NV Purchaser”), a Nevada corporation, Iowa Shrimp Holdings, LLC (“IA Purchaser”), an Iowa limited liability company, Texas Shrimp Holdings, LLC (“TX Purchaser” or together with NV Purchaser and IA Purchaser, the “Purchasers”), a Texas limited liability company, for a roughly $35,703,789.87 credit bid (based on a secured and administrative claim basis) and $100,000 cash, pursuant to the terms and conditions set forth in that certain Asset Purchase Agreement (“APA”) between Trustee and Purchasers. The order to sell the assets was approved on March 30, 2025 and the title to the assets was transferred to the lenders on May 14, 2025.

 

Intellectual Property Agreement with Hydrenesis, Inc.

 

During March of 2026, NaturalShrimp Incorporated entered into an Intellectual Property Acquisition and Management Transition Agreement (the “Agreement”) with Hydrenesis, Inc., a Florida corporation (“Hydrenesis”), and David Antelo. Pursuant to the agreement:

 

  ● The Company agreed to transition its operations toward the commercialization of aquaculture and water treatment technologies
     
  ● Certain governance and control rights were transferred
     
  ● Hydrenesis agreed to grant the Company a license to certain intellectual property, technology rights, know-how, and related commercialization rights, subject to the terms and conditions of the agreement
     
  ● The Company’s outstanding obligation to Hydrenesis in the amount of approximately $1.3 million will be converted into equity at Closing. The amount was forgiven during the three months ended September 30, 2026.
     
  ● The Company approved and executed Certificates of Designation for Series P, Series P-2, and Series L Preferred Stock, which are expected to be filed with the Nevada Secretary of State;
     
  ● Existing liabilities, obligations, and legacy securities, including Series A Preferred Stock and Series F Preferred Stock, will be restructured, amended, cancelled, or exchanged into Series L Preferred Stock. Both the Series A and Series F preferred shares were cancelled during the interim period ended September 30, 2026.

 

16

 

 

On June 25, 2026, NaturalShrimp Inc, Hydrenesis, Inc., and David Antelo entered into a First Amendment to the Intellectual Property Acquisition and Management Transition Agreement and Amended and Restated Perpetual Field-of-Use License Terms (the “Amendment”). The amendment confirmed that the intellectual property transfer contemplated by the original agreement did not occur. Instead, effective June 25, 2026, Hydrenesis granted the Company a perpetual, worldwide, exclusive, and sublicensable license to use and commercialize the licensed technology in aquaculture and related fields. However, as of September 30, 2026, No Series P or Series L preferred shares were issued.

 

Liquidity and Capital Resources

 

The Company had limited liquidity as of September 30, 2026 and is currently working on a plan with its existing creditors in hopes to settle its outstanding obligations through the issuance of preferred shares. In addition, the Company also hopes to finalize an equity line of credit and to raise capital through the future issuance of Series Q preferred shares. To that extent, on October 19, 2026 the Company raised $50,000 in gross proceeds for (to be issued) 50 Series Q preferred shares.

 

Results of Operations

 

During the three months ended September 30, 2026, the Company’s results of operations were limited and were primarily comprised of basic operating expenses. While certain loans and payables were forgiven during the period, all amounts were recognized as a capital contribution. Further, as a result of moving to the going concern basis of accounting during June of 2026 the Company has not presented going concern financial statements for the comparative period.

 

Critical Accounting Estimates

 

Liquidation Basis of Accounting

 

In accordance with ASC 205-30, Liquidation Basis of Accounting, the Company prepares its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is considered imminent when either of the following occurs-i) A plan for liquidation has been approved by the person or persons with the authority to make such a plan effective, and the likelihood is remote that either execution of the plan will be blocked by other parties or the entity will return from liquidation and ii) A plan for liquidation is imposed by other forces, and the likelihood is remote that the entity will return from liquidation.

 

When using the liquidation basis of accounting, the Company will i) recognize other items that is previously had not recognized but it expects to sell in liquidation or use to settle liabilities ii) accrue costs and income that it expects to incur or earn through the end of its liquidation if and when it has a reasonable basis for estimation iii) measure its assets to reflect the estimated amount of cash or other consideration that it expects to collect in settling or disposing of those assets in carrying out its plan for liquidation and iv) measure its liabilities in accordance with the measurement provision of other topics that it would otherwise apply to those liabilities.

 

Recently Issued Accounting Standards

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40). The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses at each interim and annual reporting period. The amendments are effective for annual periods beginning after December 15, 2026, and reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of the new ASU to its financial statements.

 

17

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not Applicable. As a smaller reporting company, we are not required to provide the information required by this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We maintain a system of disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to provide reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.

 

In designing and evaluating our disclosure controls and procedures, management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

The Company’s management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, as of the end of the period covered by this Report.

 

Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of September 30, 2026, our disclosure controls and procedures were not effective due to the material weaknesses in internal control over financial reporting described below. Thus, there remains a reasonable possibility that a material misstatement of the Company’s interim financial statements will not be prevented or detected on a timely basis. This does not include an evaluation by the Company’s registered public accounting firm regarding the Company’s internal control over financial reporting. Accordingly, we cannot provide reasonable assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported, to allow our principal financial and executive officers to make timely decisions regarding required disclosures as of September 30, 2026.

 

Management’s evaluation was based on the following material weaknesses in our internal control over financial reporting which existed as of March 31, 2026, and which continue to exist, as discussed in the Company’s Annual Report on Form 10-K:

 

● Inadequate segregation of duties consistent with control objectives;
● Lack of independent board of directors (as of the balance sheet date) and absence of an audit committee to exercise oversight responsibility related to financial reporting and internal control;
● Lack of risk assessment procedures on internal controls to detect financial reporting risks in a timely manner; and
● Lack of documentation on policies and procedures that are critical to the accomplishment of financial reporting objectives.

 

Our management will continue to monitor and evaluate the relevance of our risk-based approach and the effectiveness of our internal controls and procedures over financial reporting on an ongoing basis and is committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended September 30, 2026 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

 

18

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

Not applicable

 

Item 1A. Risk Factors

 

As a smaller reporting Company (“SRC”) we are not required to provide this information.

 

Item 2. Unregistered Sales of Equity Securities and Use Of Proceeds

 

On July 30, 2026, the Company sold 49 Series M preferred shares to an investor for gross proceeds of $49,000. The preferred shares were issued upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933.

 

Item 3. Defaults upon Senior Securities

 

As of September 30, 2026, the Company had defaulted on $1,079,832 of notes payable. The Company is in active negotiations with the creditors, which are primarily former employees, to settle the outstanding loans. Further, the Company has also defaulted on its payment of $933,993 of accrued dividends stemming from its Series E and G preferred shares. Similar to the notes payable, the Company is in active negotiations with the preferred shareholders to settle the outstanding dividends payable.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

EXHIBIT INDEX

 

        Incorporated by Reference
Exhibit Number   Exhibit Description   Form   Exhibit
31.1*   Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.        
32.1**   Section 1350 Certification of Chief Executive Officer.        
101.INS*   Inline XBRL Instance Document        
101.SCH*   Inline XBRL Taxonomy Extension Schema Document        
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document        
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document        
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document        
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document        

 

* Filed herewith.

** Furnished herewith.

 

19

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

NATURALSHRIMP INCORPORATED

 

By: /s/ David Antelo  
  David Antelo  
  Chief Executive Officer and Chief Financial Officer  
Date: November 10, 2026  

 

20

 

Keep reading